![Yves Ribeill](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yves Ribeill
Amministratore Delegato presso
Ribogenics, Inc.
Profilo
Yves Joseph Ribeill is the founder of SCYNEXIS, Inc., founded in 1999, where the title held was Director from 2015 to 2016.
Current jobs include Chief Executive Officer at Enodia Therapeutics, President & Chief Executive Officer at Ribogenics, Inc., President & Chief Executive Officer at COREzonada, Inc. since 2017, and Director at Ogeda SA. Former jobs include Executive Chairman at Calyxt, Inc. in 2021, Director at Synergia Medical SA, Principal at Rhone-Poulenc Rorer, Inc., and Principal at Aventis Pharma SA in 2000.
Education includes a doctorate from Université de Montpellier.
Posizioni attive di Yves Ribeill
| Società | Posizione | Inizio |
|---|---|---|
Ogeda SA
 Ogeda SA Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule drugs | Direttore/Membro del Consiglio | 28/08/2009 |
COREzonada, Inc.
 COREzonada, Inc. BiotechnologyHealth Technology Operates as a biotechnology company working on microbiome re-engineering | Amministratore Delegato | 01/08/2017 |
Ribogenics, Inc.
 Ribogenics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Amministratore Delegato | - |
Precedenti posizioni note di Yves Ribeill
| Società | Posizione | Fine |
|---|---|---|
| SCYNEXIS, INC. | Fondatore | 16/03/2016 |
Aventis Pharma SARL
 Aventis Pharma SARL Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Corporate Officer/Principal | 01/01/2000 |
Synergia Medical SA
 Synergia Medical SA Packaged SoftwareTechnology Services Develops optoelectronics for neurostimulation medical devices | Direttore/Membro del Consiglio | - |
Calyxt, Inc.
 Calyxt, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as clinical-stage biotechnology company, engages in development and commercialization of products derived from plant cells | Amministratore Delegato | 01/10/2018 |
Rhone-Poulenc Rorer, Inc.
 Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets human pharmaceuticals | Corporate Officer/Principal | - |
Formazione di Yves Ribeill
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
46
Relazioni di 1° grado
9
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets human pharmaceuticals | Health Technology |
SCYNEXIS, Inc.
 SCYNEXIS, Inc. Pharmaceuticals: MajorHealth Technology Develops novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections | Health Technology |
Aventis Pharma SARL
Aventis Pharma SARL Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Université de Montpellier
 Université de Montpellier Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ogeda SA
Ogeda SA Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule drugs | Health Technology |
Calyxt, Inc.
Calyxt, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as clinical-stage biotechnology company, engages in development and commercialization of products derived from plant cells | Commercial Services |
Synergia Medical SA
Synergia Medical SA Packaged SoftwareTechnology Services Develops optoelectronics for neurostimulation medical devices | Technology Services |
Ribogenics, Inc.
Ribogenics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
COREzonada, Inc.
COREzonada, Inc. BiotechnologyHealth Technology Operates as a biotechnology company working on microbiome re-engineering | Health Technology |
